The neurophysiology devices and equipment market size has grown marginally in recent years. It will grow from $1.72 billion in 2025 to $1.76 billion in 2026 at a compound annual growth rate (CAGR) of 2.3%. The growth in the historic period can be attributed to growth in neurological testing, advancements in EMG and EEG, increasing surgical volumes, expansion of hospital neurology departments, clinical research growth.
The neurophysiology devices and equipment market size is expected to see strong growth in the next few years. It will grow to $2.51 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to demand for point-of-care diagnostics, rising prevalence of nerve disorders, technological miniaturization, expansion of ambulatory centers, increasing training and education programs. Major trends in the forecast period include rising adoption of portable neurophysiology devices, increased use in intraoperative monitoring, growing demand for wireless recording systems, expansion of neurology and neurodiagnostic labs, focus on early detection of nerve disorders.
The primary factor supporting the expansion of the neurophysiology device and equipment market is the increasing global prevalence of neurological disorders. Neurological disorders are considered among the most widespread recurring health conditions worldwide. There are more than 600 identified neurological disorders, including brain tumors, epilepsy, Parkinson’s disease, and Alzheimer’s disease. These conditions are ranked among the leading causes of Disability Adjusted Life Years (DALYs), which represent the number of years lost due to ill health, disability, or premature death. The rising number of neurological disease cases and the growing patient population are contributing to higher demand for devices used in the diagnosis and treatment of these disorders. For example, in February 2023, according to Cancer Research UK, a UK-based charity, the average annual number of new brain, other central nervous system, and intracranial tumor cases in the UK is projected to increase from approximately 12,600 during 2023-2025 to around 13,600 by 2038-2040. This trend is increasing the need for medical devices used in neurological care, thereby supporting the neurophysiology device and equipment market during the forecast period.
Government initiatives supporting next-generation invasive devices are expected to propel growth of the neurophysiology devices and equipment market. Government initiatives include policies, programs, and funding mechanisms designed to promote innovation and clinical adoption of advanced medical technologies. For example, in 2023, according to the US Department of Health and Human Services, the National Institutes of Health issued a funding opportunity announcement encouraging early-stage and first-in-human clinical studies for next-generation invasive devices. These initiatives are accelerating innovation and driving demand for advanced neurophysiology devices and equipment.
Major companies operating in the neurophysiology devices and equipment market are introducing innovative products such as Evo sEEG electrodes to drive revenue growth. The Evo sEEG electrode is a high-definition, minimally invasive thin-film electrode developed for the diagnosis and treatment of multiple neurological disorders. For example, in May 2023, NeuroOne Medical Technologies Corporation, a US-based medical technology company, launched Evo sEEG electrodes. The Evo sEEG electrode also holds potential for future applications in spinal cord stimulation and ablation therapies. These electrodes incorporate high-definition thin-film technology that may enhance signal clarity while enabling secure, precise, and less invasive diagnostic procedures for patients with conditions such as epilepsy, chronic back pain, and Parkinson’s disease.
Major companies operating in the neurophysiology devices and equipment market are Medtronic Plc, Nihon Kohden Corporation, Dr. Langer Medical GmbH, Natus Medical Incorporated, Inomed Medizintechnik, NuVasive Inc, Axon Healthcare Ltd., Bovie Medical Corporation, Neurosign, Neurowave Systems, Cadwell Industries, Brainsway, Checkpoint Surgical, Deymed Diagnostic Inc., EMS Biomedical, Compumedics Limited, Magtism, Langer Medical, Shanghai NCC Medical, Ambu, Blackrock Microsystems, Cognionics, Morningside Medical Equipment, BeckerSmith Medical, Cognivue, Helius Medical Technologies, inTRAvent Medical Partners, Neural Diagnostics Pty Ltd, Irras AB.
North America was the largest region in the neurophysiology devices and equipment market in 2025. Western Europe was the second-largest region in the global neurophysiology devices and equipment market share. The regions covered in the neurophysiology devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the neurophysiology devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the neurophysiology devices market by increasing costs of electrodes, sensors, and electronic components, particularly affecting portable and wireless systems in Asia-Pacific manufacturing regions. Hospitals and ambulatory centers have faced higher procurement costs. Positive impacts include increased local manufacturing initiatives and improved supplier diversification.
The neurophysiology devices and equipment market research report is one of a series of new reports that provides neurophysiology devices and equipment market statistics, including neurophysiology devices and equipment industry global market size, regional shares, competitors with a neurophysiology devices and equipment market share, detailed neurophysiology devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the neurophysiology devices and equipment industry. This neurophysiology devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Neurophysiology devices and equipment measure and assess nervous system functions, including spinal cord, brain, and peripheral nerve activity, to identify dysfunctions and nerve damage.
The main technologies used in neurophysiology devices include electromyography (EMG), electroencephalography (EEG), electrocorticography (ECoG), and evoked potential (EP) techniques. Electromyography (EMG) is a diagnostic method used to evaluate muscle health and the nerve cells that control muscle activity. EMG findings can identify nerve dysfunction, muscle disorders, or abnormalities in nerve-to-muscle signal transmission. Neurophysiology devices are available as standalone or portable systems and are used by end users such as hospitals and ambulatory surgical centers.
The neurophysiology devices and equipment market consist of sales of devices and instruments for nerve conduction studies. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The neurophysiology devices and equipment market size is expected to see strong growth in the next few years. It will grow to $2.51 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to demand for point-of-care diagnostics, rising prevalence of nerve disorders, technological miniaturization, expansion of ambulatory centers, increasing training and education programs. Major trends in the forecast period include rising adoption of portable neurophysiology devices, increased use in intraoperative monitoring, growing demand for wireless recording systems, expansion of neurology and neurodiagnostic labs, focus on early detection of nerve disorders.
The primary factor supporting the expansion of the neurophysiology device and equipment market is the increasing global prevalence of neurological disorders. Neurological disorders are considered among the most widespread recurring health conditions worldwide. There are more than 600 identified neurological disorders, including brain tumors, epilepsy, Parkinson’s disease, and Alzheimer’s disease. These conditions are ranked among the leading causes of Disability Adjusted Life Years (DALYs), which represent the number of years lost due to ill health, disability, or premature death. The rising number of neurological disease cases and the growing patient population are contributing to higher demand for devices used in the diagnosis and treatment of these disorders. For example, in February 2023, according to Cancer Research UK, a UK-based charity, the average annual number of new brain, other central nervous system, and intracranial tumor cases in the UK is projected to increase from approximately 12,600 during 2023-2025 to around 13,600 by 2038-2040. This trend is increasing the need for medical devices used in neurological care, thereby supporting the neurophysiology device and equipment market during the forecast period.
Government initiatives supporting next-generation invasive devices are expected to propel growth of the neurophysiology devices and equipment market. Government initiatives include policies, programs, and funding mechanisms designed to promote innovation and clinical adoption of advanced medical technologies. For example, in 2023, according to the US Department of Health and Human Services, the National Institutes of Health issued a funding opportunity announcement encouraging early-stage and first-in-human clinical studies for next-generation invasive devices. These initiatives are accelerating innovation and driving demand for advanced neurophysiology devices and equipment.
Major companies operating in the neurophysiology devices and equipment market are introducing innovative products such as Evo sEEG electrodes to drive revenue growth. The Evo sEEG electrode is a high-definition, minimally invasive thin-film electrode developed for the diagnosis and treatment of multiple neurological disorders. For example, in May 2023, NeuroOne Medical Technologies Corporation, a US-based medical technology company, launched Evo sEEG electrodes. The Evo sEEG electrode also holds potential for future applications in spinal cord stimulation and ablation therapies. These electrodes incorporate high-definition thin-film technology that may enhance signal clarity while enabling secure, precise, and less invasive diagnostic procedures for patients with conditions such as epilepsy, chronic back pain, and Parkinson’s disease.
Major companies operating in the neurophysiology devices and equipment market are Medtronic Plc, Nihon Kohden Corporation, Dr. Langer Medical GmbH, Natus Medical Incorporated, Inomed Medizintechnik, NuVasive Inc, Axon Healthcare Ltd., Bovie Medical Corporation, Neurosign, Neurowave Systems, Cadwell Industries, Brainsway, Checkpoint Surgical, Deymed Diagnostic Inc., EMS Biomedical, Compumedics Limited, Magtism, Langer Medical, Shanghai NCC Medical, Ambu, Blackrock Microsystems, Cognionics, Morningside Medical Equipment, BeckerSmith Medical, Cognivue, Helius Medical Technologies, inTRAvent Medical Partners, Neural Diagnostics Pty Ltd, Irras AB.
North America was the largest region in the neurophysiology devices and equipment market in 2025. Western Europe was the second-largest region in the global neurophysiology devices and equipment market share. The regions covered in the neurophysiology devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the neurophysiology devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the neurophysiology devices market by increasing costs of electrodes, sensors, and electronic components, particularly affecting portable and wireless systems in Asia-Pacific manufacturing regions. Hospitals and ambulatory centers have faced higher procurement costs. Positive impacts include increased local manufacturing initiatives and improved supplier diversification.
The neurophysiology devices and equipment market research report is one of a series of new reports that provides neurophysiology devices and equipment market statistics, including neurophysiology devices and equipment industry global market size, regional shares, competitors with a neurophysiology devices and equipment market share, detailed neurophysiology devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the neurophysiology devices and equipment industry. This neurophysiology devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Neurophysiology devices and equipment measure and assess nervous system functions, including spinal cord, brain, and peripheral nerve activity, to identify dysfunctions and nerve damage.
The main technologies used in neurophysiology devices include electromyography (EMG), electroencephalography (EEG), electrocorticography (ECoG), and evoked potential (EP) techniques. Electromyography (EMG) is a diagnostic method used to evaluate muscle health and the nerve cells that control muscle activity. EMG findings can identify nerve dysfunction, muscle disorders, or abnormalities in nerve-to-muscle signal transmission. Neurophysiology devices are available as standalone or portable systems and are used by end users such as hospitals and ambulatory surgical centers.
The neurophysiology devices and equipment market consist of sales of devices and instruments for nerve conduction studies. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Neurophysiology Devices and Equipment Market Characteristics
3. Neurophysiology Devices and Equipment Market Supply Chain Analysis
4. Global Neurophysiology Devices and Equipment Market Trends and Strategies
5. Neurophysiology Devices and Equipment Market Analysis of End Use Industries
7. Global Neurophysiology Devices and Equipment Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Neurophysiology Devices and Equipment Total Addressable Market (TAM) Analysis for the Market
9. Neurophysiology Devices and Equipment Market Segmentation
10. Neurophysiology Devices and Equipment Market Regional and Country Analysis
11. Asia-Pacific Neurophysiology Devices and Equipment Market
12. China Neurophysiology Devices and Equipment Market
13. India Neurophysiology Devices and Equipment Market
14. Japan Neurophysiology Devices and Equipment Market
15. Australia Neurophysiology Devices and Equipment Market
16. Indonesia Neurophysiology Devices and Equipment Market
17. South Korea Neurophysiology Devices and Equipment Market
18. Taiwan Neurophysiology Devices and Equipment Market
19. South East Asia Neurophysiology Devices and Equipment Market
20. Western Europe Neurophysiology Devices and Equipment Market
21. UK Neurophysiology Devices and Equipment Market
22. Germany Neurophysiology Devices and Equipment Market
23. France Neurophysiology Devices and Equipment Market
24. Italy Neurophysiology Devices and Equipment Market
25. Spain Neurophysiology Devices and Equipment Market
26. Eastern Europe Neurophysiology Devices and Equipment Market
27. Russia Neurophysiology Devices and Equipment Market
28. North America Neurophysiology Devices and Equipment Market
29. USA Neurophysiology Devices and Equipment Market
30. Canada Neurophysiology Devices and Equipment Market
31. South America Neurophysiology Devices and Equipment Market
32. Brazil Neurophysiology Devices and Equipment Market
33. Middle East Neurophysiology Devices and Equipment Market
34. Africa Neurophysiology Devices and Equipment Market
36. Neurophysiology Devices and Equipment Market Competitive Landscape and Company Profiles
37. Neurophysiology Devices and Equipment Market Other Major and Innovative Companies
40. Neurophysiology Devices and Equipment Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Neurophysiology Devices And Equipment Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses neurophysiology devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for neurophysiology devices and equipment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neurophysiology devices and equipment market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Technology: Electromyography (EMG); Electroencephalography (EEG); Electrocorticography (ECoG); Evoked Potential (EP)2) By Modality: Standalone; Portable
3) By End Users: Hospitals; Ambulatory Surgical Centers
Subsegments:
1) By Electromyography (EMG): Surface EMG Devices; Needle EMG Devices; Wireless EMG Devices2) By Electroencephalography (EEG): Conventional EEG Systems; Portable EEG Systems; Wireless EEG Systems
3) By Electrocorticography (ECoG): Grid Electrodes; Strip Electrodes; Subdural Electrodes
4) By Evoked Potential (EP): Visual Evoked Potential (VEP) Devices; Auditory Evoked Potential (AEP) Devices; Somatosensory Evoked Potential (SEP) Devices
Companies Mentioned: Medtronic Plc; Nihon Kohden Corporation; Dr. Langer Medical GmbH; Natus Medical Incorporated; Inomed Medizintechnik; NuVasive Inc; Axon Healthcare Ltd.; Bovie Medical Corporation; Neurosign; Neurowave Systems; Cadwell Industries; Brainsway; Checkpoint Surgical; Deymed Diagnostic Inc.; EMS Biomedical; Compumedics Limited; Magtism; Langer Medical; Shanghai NCC Medical; Ambu; Blackrock Microsystems; Cognionics; Morningside Medical Equipment; BeckerSmith Medical; Cognivue; Helius Medical Technologies; inTRAvent Medical Partners; Neural Diagnostics Pty Ltd; Irras AB
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Neurophysiology Devices and Equipment market report include:- Medtronic Plc
- Nihon Kohden Corporation
- Dr. Langer Medical GmbH
- Natus Medical Incorporated
- Inomed Medizintechnik
- NuVasive Inc
- Axon Healthcare Ltd.
- Bovie Medical Corporation
- Neurosign
- Neurowave Systems
- Cadwell Industries
- Brainsway
- Checkpoint Surgical
- Deymed Diagnostic Inc.
- EMS Biomedical
- Compumedics Limited
- Magtism
- Langer Medical
- Shanghai NCC Medical
- Ambu
- Blackrock Microsystems
- Cognionics
- Morningside Medical Equipment
- BeckerSmith Medical
- Cognivue
- Helius Medical Technologies
- inTRAvent Medical Partners
- Neural Diagnostics Pty Ltd
- Irras AB
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.76 Billion |
| Forecasted Market Value ( USD | $ 2.51 Billion |
| Compound Annual Growth Rate | 9.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 30 |
